EIF4E and breast carcinoma: Galeterone decreased the proliferation of breast cancer cell lines MDAMB-231, MDA-MB-68, Hs 578T, and BT-549, with IC50 values ranging from 0.5 to 4 μM, all due to inhibiting the MNK-eIF4E axis.